Parkinson’s Disease – How PEMF Therapy Works?

PEMF therapy for Parkinson’s disease has been researched and applied. There are many trials to test the effectiveness of pulsed electromagnetic fields as a treatment for Parkinson’s disease. PEMF therapy works well for Parkinson’s symptoms because it has protective effects. Let us learn about Parkinson’s disease and then see how PEMF therapy works and benefits Parkinson’s disease as per available research.

Parkinson’s disease is a common modern ailment and the prevalence of this cerebral disease is increasing. The world has gotten polluted in the 20th century and there are links to Parkinson’s disease.

Parkinson’s disease is a progressive disorder of brain function due to the loss of nerve cells in the part of the brain known as substantia nigra, which affects hormones and neurotransmitters. The experts believe that the brain region becomes hyper active in people with Parkinson’s due to the loss of dopamine.

psychiatrist near me-therapy-for-parkinson-s-disease-image-2.jpg”/>

How does PEMF therapy work?

Magnetic fields are used for regeneration and functional improvement in pulsed field therapy. The stimulation of the brain with transcranial magnetic stimulation increases circulation to the brain and stimulates brain mitochondria, the powerhouses of cells. Natural cellular regeneration and repair are increased by these changes.

More than 6 decades of research and thousands of studies have led to the evolution of pulse magnetic therapy devices. There are a number of terms used to describe brain stimulating magnetic fields. All are similar technologies and have different design. We consider the studies of all the above technologies when we study the available research on treating Parkinson’s disease using PEMF therapy.

PEMF therapy research for Parkinson’s disease

Studies show that PEMF therapy improves gross and fine-motor function. The reactivity of molecules is altered by the magnetic fields. Aging related degeneration slows down with fewer free radicals. Up to 40% of Parkinson’s patients have depression and PEMF therapy can help.

PEMFs can help with physical therapy and neurological rehabilitation.

There have been published research on the effects of PEMF therapy on Parkinson’s disease.

A patient with a 10 year history of Parkinson’s disease was treated by Dr. Reuven Sandyk from the Institute for Biomedical Engineering and Rehabilitation Services of Touro College, NY. Within a week of PEMF therapy, there was a complete disappearance of Parkinson’s disease tremors. He was able to get his signature back.

In 1999, his research showed that AC PEMF therapy improves smell in Parkinson’s disease. He noticed that 7 Hz stimulation was helpful in resolving olfactory function, which is often ignored in treatment of Parkinson’s disease. The smell and yawning are indicators of disease status and can be seen as signs of treatment working.

Dr. Sandyk is one of the key scientists from the US involved in early research on the effects of PEMF therapy for Parkinson’s disease. He found improvements in speech impairment and restless leg syndrome among the benefits.

A study done in 2015 by reputed researchers from Italy, Mexico and the UK concluded that PEMFs improve Parkinson’s disease symptoms including slowness of movement and difficulty in walking. It is safe and improves the quality of life for patients with Parkinson’s disease.

A large review of patients with Parkinson’s disease from 2015 concluded that rTMS improves their symptoms.

The benefits of PEMF therapy for Parkinson’s disease were studied in a randomized clinical trial. They used a 50 Hz PEMF field for 30 minutes and found that it helped Parkinson’s patients rise up from their chairs faster. Mild Parkinson’s has the best results. The results may have been better if 10 Hz was used instead to reprogram neural stem cells, according to a paper from NASA.

There is more research on PEMF therapy for Parkinsons, in addition to the research review articles presented above. We hope you find the information useful in your search for PEMF therapy.

PEMF therapy for Parkinson’s Disease Research References

(1-9 cited in article), Further reading: 10-32

1. Parkinsonism Relat Disord is a disease. Vonloh M, Chen R, Kluger B review the safety of transcranial magnetic stimulation in Parkinson’s disease. The article is titled “19(6):573-585.” The journal is about Psychiatry. The treatment of depression with transcranial pulsed electromagnetic fields is a mechanistic point of view. The article is titled ” 71:137-143.” There is a disease called neurology. The clinical features and treatment of depression associated with Parkinson’s disease are described. The 2002;58(4 Suppl 1) is titled:S63-70. Int J Neurosci. Sandyk R wrote about brief communication that improves visuospatial performance and reverses agraphia in a parkinsonian patient. The 96;87(3-4):23-279. Int J Neurosci. Sandyk R. said that treatment with AC pulsed electromagnetic fields improves olfactory function in Parkinson’s disease. The 97(3-4):225-233 was published in 1999. Int J Neurosci. Sandyk R. said that speech impairment in Parkinson’s disease is improved by transcranial application of the electromagnetic fields. The 95(1-2):63-72 was published in 1997. Int J Neurosci. Sandyk, Iacono, and Bamford collaborated on a study on the mechanisms of restless legs syndrome. The article was titled “38 (1-2):121-1 24.” Behav Brain Funct. The mechanisms and therapeutic applications of electromagnetic therapy in Parkinson’s disease are discussed. The article is titled “11:26.” One journal. The effect of transcranial pulsed electromagnetic fields on force development and movement speed. The journal’s website has a link to the article titled “13(9):e0204478”. Int J Neurosci. Sandyk R. a drug naive parkinsonian patient successfully treated with weak electromagnetic fields. The 81(1-2):99-110 was published in 1994. Int J Psychopharmacol is a journal. The left prefrontal cortex is involved in Parkinson’s disease. The 11(2):173-183 was published in 2008. Srp Arh is named after a person. The 2001;129(9-10):235-238 was published. Potrebi A, Dragasevi N, Svetel M, and Kosti V. There is an effect of slow repetitive transcranial magnetic stimulation on depression in patients with Parkinson’s disease. The journal 2001;129(9-10):235-238 was published. Int J Neurosci. Sandyk R. said weak electromagnetic fields reverse visuospatial hemi-inattention in Parkinson’s disease. The 1995; 81(1-2):47-65 was published in 1995. Int J Neurosci. Sandyk R. said that treatment with AC pulsed electromagnetic fields improves the response to levodopa. The 95(3-4):189-197 was published in 1997. Arch Neurological. The study was conducted with controlled stimulation of the cerebellum. The 2002;59(3):413- 417 was published in the Archives. J Neuroscience. The mechanism of repetitive transcranial magnetic stimulation in Parkinson’s disease is studied. The 2001;248 Suppl 3:III48-52 is available on the internet. Front of brain. The effectiveness of brain stimulation in improving clinical signs of hyperkinetic movement disorders. The article is titled: 9:486 and it was published on thefnins.2015. Brain smul. The retention of a motor skill in Parkinson’s disease is improved by the use of TMS. The 8(2), pp.224-230, is available at: www.brs.com. There is a disease called neurology. The Research Committee on rTMtMS Treatment of Parkinson’s Disease was published in the 80(15):1400-1405. A randomized controlled study was conducted on supplementary motor area stimulation for Parkinson disease. The article was titled: “80(15):1400-1405. Clinical neurology and neurosurgery. Cohen OS, Orlev Y, Yahalom G, and others are writing about a feasibility study about repetitive deep transcranial magnetic stimulation for Parkinson’s disease. January 2016 edition of clineuro. TherTMS therapy in Parkinson Disease: A Meta-Analysis was published in the 8(4) of PM R. The article is titled “8(4): 355-366.” Panminerva Med. 1994;36(4):199-206. The treatment of neurological disorders involves the use of magnetic fields. The journal of the National Center for Biologicall Medicine, 36(4):201- 205. Brain Topogr. The analysis of brain activity in Parkinson patients was done in 2000. The article was published in 2000 and can be found in the following pages: 13(2):135-144. J Clin Neurosci. Sayn S, Cakmur R, Yener G, Yaka E, Uurel B, Uzunel F, and a group of people discuss low-frequency repetitive transcranial magnetic stimulation for Parkinson’s. The article was published in the 21(8):1373-1376. The cerebellum is a plant. Is the cerebellum a target for stimulation in Parkinson’s disease? Results of upper limb motor tasks. The article was published in 2011;10(4):804-811. Brain smul. Spagnolo F, Coppi E, Chieffo R, and others are involved in a study on Parkinson’s disease. The journal of the brs was published in 2013;6(6):892-897. Int J Neurosci. Sandyk R. Improvement in word-fluency performance in Parkinson’s disease by administration of electromagnetic fields. The following year, 1994; 77(1-2):23-46. Int J Neurosci. Sandyk R. said that Parkinson’s disease causes weak electromagnetic fields that can improve short-term visual memory. The 1995; 81(1-2):67-87 was published in the journal. Int J Neurosci. Sandyk R. said that the treatment of Parkinson’s disease with weak electromagnetic fields improved the freezing of the gait. The 1996 edition of 85 (1-2) was published in 1996. Restor Neuroscience. Lee S, Kim M, Chang W, Cho J, Youn J, and Kim Y studied the effects of repetitive transcranial magnetic stimulation on freezing gait in Parkinsonism patients. The article was titled “32(6):743-753.” There is a disease called neurology. The paper was about Parkinson’s disease. I. The effects of repetitive transcranial motor cortex stimulation. The 44(5):892-898 was published in 1994. Panminerva Med. The 37(2), was published in 1995. A mechanism for treating neurologic disorders with magnetic fields. The National Center for Biologicall Medicine, a part of the National Institute of Health, published 37(2),98-104.

Leave a Reply

Your email address will not be published.

You May Also Like